Skip to content
View Creative Blog

The Zimbabwean Government Turns Down ‘One-Sided’ American Healthcare Assistance Agreement Because of Information Concerns

Health funding image
The proposed American funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has turned down a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' request for sensitive biological samples.

This move was revealed after a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".

A government representative later explained that the US was seeking genetic material for scientific study and commercial purposes while refused to guarantee the resulting advantages from any future medical innovations.

"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for more talks to find a agreement acceptable to all parties so the country's critical HIV programme can be sustained.

Wider Background

Zimbabwe's decision comes after a comparable situation in Kenya, where a court suspended a related health funding agreement following concerns were filed about the safety of Kenyans' health data.

After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking direct bilateral agreements to enhance openness and responsibility.

Based on statements, 16 nations in Africa have so far signed these new agreements, representing over $18.3bn in committed funds.

Details of the Rejected Agreement

The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this cooperation could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," Tremont commented.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to share its genetic material and health information over an extended period, without any equivalent assurance of access to any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.

"Put simply, our country would provide the raw materials for medical research without any assurance that the resulting innovations would be available to our population if a new pandemic emerge."

National Interest and Global Health

Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining systems already established via the global organization.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.

"This system is designed to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."

These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We are open to continued dialogue with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and dignity of both nations."

Health Experts Reaction

Medical experts stated it understood the government's concerns, but recommended that talks must proceed given that much of the country's Aids initiatives were funded by foreign aid.

"If specific concerns exist, such as those relating to data governance or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.

The situation underscores the complex debate between receiving crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.

The writer

Samantha Scott

A digital artist and design educator with over a decade of experience in visual storytelling and creative direction.

View Creative Blog

Type to search articles.